Feb 2mRNA vaccines20Med Therapeutics and CEPI Sign Agreement to Advance ThermoStable Vaccines TechnologyCEPI to initially provide up to USD850,000 to 20Med to advance development of 20Med’s bioresponsive polymeric nanoparticle platform for...
Jun 1, 2021mRNA vaccines20Med Therapeutics started research into mRNA vaccines against variants of the SARS-CoV-2 virusThe SARS-CoV-2 pandemic has shown the need to be prepared for an outbreak of an infectious disease. It spurred one of the most promising...